Adaptimmune Therapeutics PLC ADR ADAPY
Trading Information
- Previous Close Price
- $0.03
- Day Range
- $0.03–0.03
- 52-Week Range
- $0.00–0.24
- Bid/Ask
- $0.03 / $0.03
- Shares Outstanding
- 265.05M
- Market Cap
- $7.53M
- Volume/Avg
- 9,186 / 256,180
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.12
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its product pipelines include ADP-600 [PRAME] and ADP-520 [CD70].
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 506
- Website
- https://www.adaptimmune.com
Valuation
|
Metric
|
ADAPY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.12 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ADAPY
|
|---|---|
Quick Ratio | 1.07 |
Current Ratio | 1.52 |
Interest Coverage | −29.20 |
Quick Ratio
ADAPY
Profitability
|
Metric
|
ADAPY
|
|---|---|
Return on Assets (Normalized) | −63.42% |
Return on Equity (Normalized) | −933.69% |
Return on Invested Capital (Normalized) | −198.83% |
Return on Assets
ADAPY
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|Sq#z$y | LOCK|?N#M | $129B | |||
| Moderna Inc
MRNA
| LOCK|<x>%Lx> | LOCK|bF | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|wM!hg! | LOCK|l&Ly@ | $77B | |||
| argenx SE ADR
ARGX
| LOCK|mT#XT^ | LOCK|&V | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|>!%bd$ | LOCK|cW | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|%&g>x& | LOCK|C!lV> | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|PffnpM@! | LOCK|yL&q | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|#v$LTR | LOCK|!< | $24B | |||
| Incyte Corp
INCY
| LOCK|BtDL^M? | LOCK|!n@ | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|^>W^&$ | LOCK|?wg | $14B |
United States